07Dec 2023
Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine

Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine

This retrospective analysis explores the epidemiology and timing of neutropenia associated with clozapine, a medication used for schizophrenia. Examining data from over 26,000 individuals, the study indicates that most serious neutropenic events leading to clozapine cessation occur within 18 weeks, becoming rare after 2 years. The findings suggest the potential for reducing monitoring frequency after the initial 18 weeks, allowing for a more personalized and efficient approach to managing neutropenia risk during clozapine treatment.

  • #neurology

Like

Save

Share